Table 1.
Patient characteristics
| Characteristic | Patients |
|---|---|
| n (%) | |
| Age, years | |
| Median | 55 |
| Range | 24–77 |
| Sex | |
| Male | 10 (50) |
| Female | 10 (50) |
| Histology | |
| PTCL-NOS | 10 (50) |
| AITL | 9 (45) |
| ALCL, ALK negative | 1 (5) |
| Stage at enrolment | |
| I–II | 1 (5) |
| III–IV | 19 (95) |
| Extranodal involvement | 10 (50) |
| International Prognostic Index | |
| ≥2 | 16 (80) |
| No. of prior regimens | |
| Median | 2 |
| Range | 1–4 |
| Refractory to most recent therapy | 12 (60) |
PTCL-NOS peripheral T-cell lymphoma not otherwise specified, AITL angioimmunoblastic T-cell lymphoma, ALCL anaplastic large cell lymphoma, ALK anaplastic lymphoma kinase